Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
personalized medicine
Biotech
Genentech scraps $2B cell therapy pact with Adaptive
The January 2019 pact with Adaptive Biotech was meant to see Genentech develop personalized cancer therapies based on Adaptive’s T-cell receptor tech.
Darren Incorvaia
Aug 18, 2025 2:40pm
Center launches with $20M to create CRISPR therapies for kids
Jul 8, 2025 11:59am
Top health agency awards $54M for tumor treatment, research
Aug 27, 2024 4:00am
Illumina, Henry Ford to explore DNA testing for heart disease
Apr 17, 2023 9:50am
GSK pays Tempus $70M to expand access to patient data library
Oct 18, 2022 8:05am
Novo pledges $200M for first quantum computer for biopharma
Sep 21, 2022 10:50am